March 31, 2017
Exercise of the over-allotment option
Media
March 28, 2017
Altimmune Receives $7.3 Million Contract Modification from BARDA to Fund Manufacturing of its First-In-Class Anthrax Vaccine Candidate NasoShield™
March 28, 2017
GenSight Biologics to Present Data on GS010 at the 43rd Annual Meeting of NANOS
March 27, 2017
Strongbridge Biopharma plc Provides Corporate Update and Reports Full-Year 2016 Financial Results
March 24, 2017
Nordic Nanovector publishes Annual Report 2016
March 23, 2017
HealthCap’s 39th IPO as HealthCap V company MIPS AB completes IPO on Nasdaq OMX Stockholm
March 23, 2017
Targovax ASA moves share listing to Oslo Børs
March 22, 2017
BioClin Therapeutics, Inc., Raises $30 Million in Series B Financing Led by Sofinnova Ventures and Ysios Capital
March 22, 2017
Nexstim Plc Signs an Independent Selling Representative Agreement in the U.S. with JTec Surgical, Inc.
March 22, 2017
Aprea Therapeutics Announces Research Collaboration with Memorial Sloan Kettering Cancer Center